BioSpace News Archive

Press Releases

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

December 5, 2024
·
8 min read
Press Releases

BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho

December 5, 2024
·
6 min read
Press Releases

N4 Pharma announces pre-clinical development of an oral RNA IBD treatment using Nuvec: N4 101

December 5, 2024
·
1 min read
Press Releases

Foresight Diagnostics Announces Launch of SHORTEN-ctDNA Trial to Evaluate Personalized Treatment Duration in DLBCL Lymphoma Patients

December 5, 2024
·
2 min read
Press Releases

Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial Launch of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007

December 5, 2024
·
5 min read
Press Releases

Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

December 5, 2024
·
2 min read
Press Releases

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2024

December 5, 2024
·
2 min read
Press Releases

Sunshine Biopharma Launches a New Generic Prescription Drug - December 4, 2024

December 5, 2024
·
3 min read
Press Releases

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

December 5, 2024
·
10 min read
Press Releases

FDA Accepts Supplemental Biologics License Application for Genentech’s Columvi Combination for People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

December 5, 2024
·
16 min read